Product Images Cetirizine Hydrochloride

This appears to be a description of a medication called "Cetirizine Hydrochloride Oral Solution, USP". It is grape flavored and intended for oral use only. The solution comes in a 4 fl oz (120 mL) bottle with dosing instructions on the label. The text also includes the National Drug Code (NDC) for the product.*

The text provides detailed information on the pharmacokinetics, interactions, special populations, effects of gender and race, pharmacodynamics, and clinical studies of cetirizine. It covers aspects such as elimination half-life, clearance, interactions with other drugs, special considerations for pediatric patients, the effect of gender, and the pharmacological actions of cetirizine on histamine-induced responses. The text also discusses the lack of race-related differences in the drug's effects and the potential interaction of cetirizine with other medications leading to QT interval prolongation. Overall, it offers valuable insights into the characteristics and effects of cetirizine in various contexts.*

This text provides detailed information on the clinical studies, indications, and usage of cetirizine hydrochloride, a medication used for the treatment of allergies. It discusses various trials conducted with different age groups, such as pediatric patients and adults with allergic rhinitis and asthma, showing the safety and efficacy of cetirizine hydrochloride in managing symptoms like sneezing, nasal discharge, and itching. The text also mentions the contraindications and precautions, highlighting the importance of being cautious while taking cetirizine hydrochloride, especially regarding activities that require alertness like driving or operating machinery.*

This text discusses drug interactions and the safety profile of Cefirzine. It mentions the impact of theophylline, erythromycin, pseudoephedrine, and ketoconazole on Cefirzine clearance, as well as potential implications for higher theophylline doses. Furthermore, the text covers carcinogenesis, mutagenesis, and impairment of fertility based on studies involving Cefirzine, noting findings from long-term use and various tests conducted on animals and humans. The information provided offers insights into the safety and potential effects of Cefirzine in different scenarios.*

This is a description of the pediatric use and safety considerations for the medication cetirizine hydrochloride. The text discusses clinical trials involving pediatric patients ranging from 6 months to 11 years old. It mentions the safety profile, recommended doses, and efficacy extrapolation from adult studies. Adverse reactions observed in pediatric patients receiving cetirizine hydrochloride include mild to moderate side effects, with common symptoms being abdominal pain and somnolence. The text highlights the need for further research regarding the safety and effectiveness of cetirizine in children under 6 months old.*

The provided text is a detailed table showing the adverse experiences reported in pediatric patients aged 6 to 11 years in placebo-controlled United States Cetirizine Hydrochloride trials. It lists various adverse effects such as headache, pharyngitis, abdominal pain, coughing, somnolence, diarrhea, nausea, and vomiting. Additionally, it includes information on adverse events observed less frequently in both adults and children over 12 years old, as well as less common side effects related to the autonomic nervous system, cardiovascular system, central and peripheral nervous systems, gastrointestinal system, genitourinary system, hearing and vestibular system, metabolic/nutritional system, musculoskeletal system, psychiatric system, respiratory system, reproductive system, reticuloendothelial system, skin, and special senses. These adverse experiences are associated with the administration of Cetirizine Hydrochloride but do not establish a causal relationship.*

This text provides detailed information about the potential side effects, over dosage, drug abuse and dependence of a medication called Cetirizine Hydrochloride. It includes dosages and administration instructions for different age groups as well as how the drug is supplied. The text also mentions post-marketing experiences and rare but severe adverse events associated with the medication. Moreover, it covers the symptoms of overdosage and outlines the supportive treatment required in case of an overdose. This text serves as a comprehensive guide for healthcare professionals and individuals using or considering the use of Cetirizine Hydrochloride.*

This text provides details about a medication. It is an oral solution of Cetirizine Hydrochloride, with a concentration of 1 mg/mL (5 mg/5 mL). The solution is grape-flavored and intended for oral use only. The usual dosage information is not provided in the text, but it advises referring to accompanying prescribing information. Storage instructions recommend keeping it at 20-25°C (68-77°F) with excursions allowed to 15-30°C (59-86°F), and also mentions the option to store it refrigerated at 2-8°C (36-46°F). The distributor information is included along with the size of the container (120 mL). The revision date for this information is 07/2024.*

This is a product label for an oral solution of cetirizine hydrochloride, with a concentration of 1 mg/mL and grape flavor. The usual dosage should be followed as per the prescribing information. It is advised to store the solution at room temperature or refrigerated. The product is distributed by Rty Pamaltig in East Brunswick, with more information available on the full Prescribing Information.*

The text provides a detailed description of Cetirizine Hydrochloride, including its chemical structure, pharmacology, pharmacokinetics, interactions, and effects in special populations such as pediatric patients. It discusses the mechanism of action of Cetirizine as an antihistamine, its absorption, distribution, metabolism, and elimination in the body. Additionally, it covers pharmacokinetic interaction studies, effects on gender, race, and dynamics of the drug. The document also mentions inhibitory effects on histamine-induced reactions and allergic inflammatory responses. It is a comprehensive overview useful for understanding the characteristics and behavior of Cetirizine Hydrochloride in the human body.*

This text provides a thorough overview of the effectiveness, safety, and indications of Cetirizine hydrochloride in treating various conditions such as allergic rhinitis and chronic urticaria in both pediatrics and adults. It also covers clinical studies, contraindications, precautions, drug interactions, and adverse reactions associated with the use of Cetirizine hydrochloride. The text emphasizes the need for caution when combining Cetirizine hydrochloride with certain medications and highlights the importance of dosage adjustments based on age and condition. It also mentions the proven safety and efficacy of Cetirizine hydrochloride in pediatric patients, with specific details provided for different age groups.*

This text provides detailed information on a placebo-controlled trial involving pediatric patients aged 6 to 24 months treated with cetirizine hydrochloride. It discusses adverse reactions, including common side effects such as abdominal pain and somnolence, as well as more rare side effects affecting various systems like the autonomic nervous system, cardiovascular system, and skin. Overdosage information for cetirizine hydrochloride is also mentioned. The text covers postmarketing reports of severe adverse events and states there is no information indicating abuse or dependency with cetirizine hydrochloride. The document illustrates different adverse experiences reported in pediatric patients aged 6 to 11 years and adults, and it offers insights into the management of overdose cases.*

This text provides information about cetirizine hydrochloride oral solution, USP including dosage and administration instructions for different age groups, storage conditions, and details about the product presentation. It explains the recommended doses for children aged 2 to 5 years and 6 months to 23 months dealing with chronic urticaria and perennial allergic rhinitis. Additionally, it mentions the maximum daily doses and storage temperatures for the product. The solution is grape-flavored and each milliliter contains 1 mg of cetirizine hydrochloride. This text is intended for medical professionals for reference purposes.*